Literature DB >> 19644131

Colonic GLP-2 is not sufficient to promote jejunal adaptation in a PN-dependent rat model of human short bowel syndrome.

Matthew C Koopmann1, Xiaowen Liu, Christopher J Boehler, Sangita G Murali, Jens J Holst, Denise M Ney.   

Abstract

BACKGROUND: Bowel resection may lead to short bowel syndrome (SBS), which often requires parenteral nutrition (PN) due to inadequate intestinal adaptation. The objective of this study was to determine the time course of adaptation and proglucagon system responses after bowel resection in a PN-dependent rat model of SBS.
METHODS: Rats underwent jugular catheter placement and a 60% jejunoileal resection + cecectomy with jejunoileal anastomosis or transection control surgery. Rats were maintained exclusively with PN and killed at 4 hours to 12 days. A nonsurgical group served as baseline. Bowel growth and digestive capacity were assessed by mucosal mass, protein, DNA, histology, and sucrase activity. Plasma insulin-like growth factor I (IGF-I) and bioactive glucagon-like peptide 2 (GLP-2) were measured by radioimmunoassay.
RESULTS: Jejunum cellularity changed significantly over time with resection but not transection, peaking at days 3-4 and declining by day 12. Jejunum sucrase-specific activity decreased significantly with time after resection and transection. Colon crypt depth increased over time with resection but not transection, peaking at days 7-12. Plasma bioactive GLP-2 and colon proglucagon levels peaked from days 4-7 after resection and then approached baseline. Plasma IGF-I increased with resection through day 12. Jejunum and colon GLP-2 receptor RNAs peaked by day 1 and then declined below baseline.
CONCLUSIONS: After bowel resection resulting in SBS in the rat, peak proglucagon, plasma GLP-2, and GLP-2 receptor levels are insufficient to promote jejunal adaptation. The colon adapts with resection, expresses proglucagon, and should be preserved when possible in massive intestinal resection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19644131      PMCID: PMC3631543          DOI: 10.1177/0148607109336597

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  37 in total

1.  METHOD FOR ASSAY OF INTESTINAL DISACCHARIDASES.

Authors:  A DAHLQVIST
Journal:  Anal Biochem       Date:  1964-01       Impact factor: 3.365

2.  EPITHELIAL HYPERPLASIA FOLLOWING MASSIVE SMALL BOWEL RESECTION IN MAN.

Authors:  R L PORUS
Journal:  Gastroenterology       Date:  1965-06       Impact factor: 22.682

3.  Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure.

Authors:  P B Jeppesen; B Hartmann; B S Hansen; J Thulesen; J J Holst; P B Mortensen
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

4.  Experimental short-bowel syndrome: effect of an elemental diet supplemented with short-chain triglycerides.

Authors:  S A Kripke; J A De Paula; J M Berman; A D Fox; J L Rombeau; R G Settle
Journal:  Am J Clin Nutr       Date:  1991-04       Impact factor: 7.045

5.  Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2.

Authors:  D G Munroe; A K Gupta; F Kooshesh; T B Vyas; G Rizkalla; H Wang; L Demchyshyn; Z J Yang; R K Kamboj; H Chen; K McCallum; M Sumner-Smith; D J Drucker; A Crivici
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

6.  Resection-induced colonic adaptation is augmented by IGF-I and associated with upregulation of colonic IGF-I mRNA.

Authors:  M P Mantell; T R Ziegler; W T Adamson; J A Roth; W Zhang; W Frankel; A Bain; J C Chow; R J Smith; J L Rombeau
Journal:  Am J Physiol       Date:  1995-12

7.  Enteral nutrients potentiate the intestinotrophic action of glucagon-like peptide-2 in association with increased insulin-like growth factor-I responses in rats.

Authors:  Xiaowen Liu; Sangita G Murali; Jens J Holst; Denise M Ney
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-10-01       Impact factor: 3.619

8.  Long-acting somatostatin analogue therapy and protein metabolism in patients with jejunostomies.

Authors:  S J O'Keefe; M W Haymond; W M Bennet; B Oswald; D K Nelson; R G Shorter
Journal:  Gastroenterology       Date:  1994-08       Impact factor: 22.682

9.  GLP-2 augments the adaptive response to massive intestinal resection in rat.

Authors:  R B Scott; D Kirk; W K MacNaughton; J B Meddings
Journal:  Am J Physiol       Date:  1998-11

10.  High-calorie total parenteral nutrition reduces hepatic insulin-like growth factor-I mRNA and alters serum levels of insulin-like growth factor-binding protein-1, -3, -5, and -6 in the rat.

Authors:  D M Ney; H Yang; S M Smith; T G Unterman
Journal:  Metabolism       Date:  1995-02       Impact factor: 8.694

View more
  7 in total

1.  Glucagon-like peptide-2 induces rapid digestive adaptation following intestinal resection in preterm neonates.

Authors:  Andreas Vegge; Thomas Thymann; Pernille Lund; Barbara Stoll; Stine B Bering; Bolette Hartmann; Jacob Jelsing; Niels Qvist; Douglas G Burrin; Palle B Jeppesen; Jens J Holst; Per T Sangild
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-06-13       Impact factor: 4.052

2.  Enteral nutrients potentiate glucagon-like peptide-2 action and reduce dependence on parenteral nutrition in a rat model of human intestinal failure.

Authors:  Adam S Brinkman; Sangita G Murali; Stacy Hitt; Patrick M Solverson; Jens J Holst; Denise M Ney
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-06-28       Impact factor: 4.052

Review 3.  Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges.

Authors:  Per T Sangild; Denise M Ney; David L Sigalet; Andreas Vegge; Douglas Burrin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-23       Impact factor: 4.052

4.  Sustained glucagon-like peptide-2 infusion is required for intestinal adaptation, and cessation reverses increased cellularity in rats with intestinal failure.

Authors:  Matthew C Koopmann; Xueyan Chen; Jens J Holst; Denise M Ney
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-09-23       Impact factor: 4.052

5.  Short Bowel Syndrome.

Authors:  Baddr A Shakhsheer; Brad W Warner
Journal:  Curr Treat Options Pediatr       Date:  2019-10-11

6.  Enhanced Ghrelin Levels and Hypothalamic Orexigenic AgRP and NPY Neuropeptide Expression in Models of Jejuno-Colonic Short Bowel Syndrome.

Authors:  Laura Gillard; Lore Billiauws; Bogdan Stan-Iuga; Lara Ribeiro-Parenti; Anne-Charlotte Jarry; Jean-Baptiste Cavin; Françoise Cluzeaud; Camille Mayeur; Muriel Thomas; Jean-Noël Freund; Jean-Marc Lacorte; Maude Le Gall; André Bado; Francisca Joly; Johanne Le Beyec
Journal:  Sci Rep       Date:  2016-06-21       Impact factor: 4.379

7.  Effects of exogenous glucagon-like peptide-2 and distal bowel resection on intestinal and systemic adaptive responses in rats.

Authors:  Sarah W Lai; Elaine de Heuvel; Laurie E Wallace; Bolette Hartmann; Jens J Holst; Mary E Brindle; Prasanth K Chelikani; David L Sigalet
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.